unknown
Stage
About
Bond Biosciences is a clinical-stage biopharmaceutical company developing non-absorbed oral therapeutics that bind excess ions in the gastrointestinal tract to treat or prevent ion-related diseases, including iron overload caused by hereditary hemochromatosis.
Explore Bond Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.